Stocks · Korea 003520 KOSPI

Yungjin Pharm

1,069원 +2.89% Market cap 1,955억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR2.14x
EPS0 KRW
BPS500 KRW
ROE-3.93%
DPS0 KRW

Returns and 52-week range

1W+3.79%
1M-3.87%
3M-10.92%
6M-39.94%
1Y-46.55%
YTD-47.21%
52W high2,320원
52W low998원
From 52W high-53.92%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
20211,961억-139억-116억-7.1%
20222,184억-74억-220억-3.4%
20232,349억31억-39억1.3%
20252,543억34억-2억1.3%
Quarterly
2024 3Q620억13억-4억2.1%
2025 1Q641억26억10억4.1%
2025 2Q625억19억3억3.0%
2025 3Q609억3,644,257원-12억0.0%
2025 4Q668억-11억-4억-1.6%
2026 1Q638억-18억-23억-2.8%

Company

CEO이기수
Founded1962-07-16
Fiscal year end12
Address: 서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층

Peers in the same sector

CompanyMarket capP/EP/B1M
녹십자웰빙1,958억19.331.72+1.40%
코오롱생명과학1,930억7.370.33+1.17%
강스템바이오텍2,083억—3.03+1.61%
한국유니온제약1,924억——+0.00%
바이넥스2,128억—1.11-2.84%
이연제약1,903억—0.85+3.33%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.